Translational Diagnostics: Advanced Training Elective
Translational Diagnostics: Advanced Training Elective supports pathology residents in hands-on diagnostic assay development training to translate molecular pathology discoveries into better patient care.
This grant was recently updated
The application deadline has been extended from November 2, 2026, to December 3, 2026.
Funder: College of American Pathologists Foundation
Due Dates: December 3, 2026 (Application deadline)
Funding Amounts: Up to $5,000 for travel and living expenses during a four-week elective in 2027
Summary: Supports hands-on training in developing novel histopathology-based diagnostic assays at Ventana Medical Systems in Tucson, Arizona.
Key Information: CAP Junior Membership and at least one completed year of residency are required, with institutional salary and benefits support.
Description
The College of American Pathologists (CAP) Foundation’s Roche-sponsored elective offers hands-on exposure to how novel histopathology-based diagnostic assays move from scientific ideas through development and validation. The four-week experience takes place in 2027 at Ventana Medical Systems’ Tucson headquarters under Shalini Singh, MD, FCAP, senior director of pathology. It focuses on translating discoveries in molecular pathology and oncology into diagnostic, prognostic, and companion diagnostic tests.
The elective introduces participants to pathologists’ roles in industry and how assay development can improve patient care through diagnostic innovation and personalized health care. A pre-elective call with Dr. Singh helps tailor the schedule to the recipient’s interests, subject to project timing and availability. Potential areas include medical innovation, pathology research and development, digital pathology, companion diagnostics, scientific and clinical affairs, tissue sample management, and platform automation and instrumentation.
